R3i Ventures Launches House of MedTech in Luxembourg einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Share:
R3i Ventures announces the launch of the House of MedTech in Luxembourg. The House of MedTech provides a fast track acceleration and commercialization pathway for companies ready for scale, from the Asia Pacific to Europe to the US, through its bases in Singapore, Luxembourg and Silicon Valley. It makes a measurable contribution to transforming societies and healthcare worldwide.
San Francisco, CA, December 20, 2020 (PR.com) Today it takes ~17 years to take a MedTech device from invention to clinical use, says R3i Ventures General Partner, Leesa Soulodre. With private health and life insurance costs on the rise globally and global shocks to supply chains, our pioneers are playing an active role in the digital transformation of healthcare, working closely with payers, industry and governments on personalised medicine, and the transition to value-based care.
Press release content from Newswire. The AP news staff was not involved in its creation.
R3i Ventures Launches House of MedTech in Luxembourg
December 18, 2020 GMT
SINGAPORE - December 18, 2020 - ( Newswire.com )
R3i has announced the launch of the House of MedTech in Luxembourg, providing a fast track acceleration and commercialization pathway for companies ready for scale, through its bases in Singapore, Luxembourg and Silicon Valley.
“Today it takes ~17 years to take a MedTech device from invention to clinical use,” says R3i Ventures General Partner, Leesa Soulodre. With private health and life insurance costs on the rise globally and global shocks to supply chains, our pioneers are playing an active role in the digital transformation of healthcare, working closely with payers, industry and governments on personalised medicine, and the transition to value-based care.”
Crucial Trigger for Glioblastoma Invasiveness Identified
December 14, 2020
Genes responsible for the extreme invasiveness of glioblastomas and the molecular regulator that switches them on have been identified by a team of scientists at the Luxemburg Institute of Health.
Glioblastomas, the most aggressive of all brain tumors, invade rapidly into normal brain tissue. The malignant cells maneuver in the tightly packed brain tissue along blood vessels to form secondary and tertiary tumors at distant locales. Once metastasis has set in, the prognosis is poor, as surgery and radio- and chemotherapy are unable to destroy the scattered glioblastoma cells. Identifying molecular players that regulate this aggressive invasiveness of glioblastoma cells is therefore of critical importance, so that they can be leveraged for drug development.
Luxembourg Institute of Health Research Sheds New Light on Glioblastoma Invasiveness chronicle.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chronicle.lu Daily Mail and Mail on Sunday newspapers.